Glyceraldehyde May Induce the Generation of High-Molecular-Weight Species of HSP90β and Autophagy-Related Proteins and Alter Protein Levels in Human Renal Epithelial Cells
Oct 2026· Biomolecules· Vol 16· 0 citations· 78 references
Medicine
TL;DR
Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
Abstract
Kidney disease (KD) is a major health problem, and metabolic disorders contribute to diabetic nephropathy and chronic kidney disease, in which renal epithelial cell dysfunction plays an important role. Intracellular advanced glycation end-products (AGEs) may contribute to KD progression by disrupting cellular homeostasis; however, the underlying mechanisms remain unclear. Therefore, we aimed to investigate the effects of glyceraldehyde (GA) on molecular chaperone- and autophagy-related proteins in human renal epithelial cells (HK-2), with particular attention to AGE-related processes. Administration of high-fructose corn syrup to healthy Wistar rats increased argpyrimidine immunoreactivity in the renal tubular epithelial cells, compared with that in controls, suggesting enhanced accumulation of this GA-related AGE in vivo. In HK-2 cells, GA treatment caused concentration-dependent reductions in NADPH and ATP levels, accompanied by morphological changes. High molecular weight (HMW) immunoreactive species of HSP90β, Beclin-1, and ATG7 appeared following GA treatment. GA at 1.5 mM increased LC3-I, LC3-II, and p62 levels, whereas treatment with 2 mM GA attenuated these increases. Aminoguanidine, an inhibitor of AGE formation, attenuated these GA-induced alterations. Overall, GA may induce the generation of HMW species of HSP90β and autophagy-related proteins and may contribute to altered cellular homeostasis, with AGE-related processes potentially contributing to these effects.
Findings support a functional miR-362-3p/SLC7A11/GPX4 axis in AGE-induced ferroptosis-associated tubular injury and provide a mechanistic basis for further in vivo and clinical validation.
Yi-Cheng Chu, Vijesh Kumar Yadav, Iat-Hang Fong et al.· Life Science· 0 citations
Findings identify hepatic CML as an AGE-related feature of steatotic liver disease and demonstrate coordinated mitochondrial, inflammatory, and fibrogenic responses to CML in multicellular HLOs, which support the utility of HLOs for investigating AGE-specific mechanisms in human liver pathology.
Jin-Young Min, Min-Ji Gu, Hye Min Kim et al.· Pharmacological Research· 0 citations
It is demonstrated that the YOD1-KEAP1 axis mediates oxidative stress injury in RTECs and highlight that targeting YOD1 represents a potential treatment approach for DKD.
Qing-Qing Zhao, Ying Zhao, Shi-Jie Fan et al.· Acta Pharmacologica Sinica· 0 citations
Diabetic nephropathy (DN) has emerged as the leading cause of end-stage renal disease, with oxidative stress injury and excessive autophagy implicated in its pathogenesis. Elevated levels of the ITIH3 protein are considered closely associated with kidney-related diseases. However, the role of ITIH3 in the progression o...
Wei-Ni Deng, Jia-Lin Jiang, Miao Lin et al.· Archives of Biochemistry and...· 0 citations
Glutaric acidemia type 1 (GA I) is caused by deficient activity of glutaryl-CoA dehydrogenase, leading to predominant accumulation of glutaric acid (GA) in the brain. GA I patients present progressive neurological deterioration whose pathophysiology is only partially elucidated. We investigated whether intracerebral GA...
E. T. Castro, Â. Zanatta, A. Carvalho et al.· Metabolic brain disease· 0 citations
Renal lipotoxicity and oxidative stress are major contributors to diabetic kidney disease (DKD), but the role of proprotein convertase subtilisin/kexin type 9 (PCSK9) and its relationship with AMP-activated protein kinase (AMPK) signaling remain unclear. We investigated the effects of PCSK9 inhibition on renal lipotoxi...
Keum-Jin Yang, Sun-Ha Lee, Sungmi Kim et al.· Antioxidants· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.